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Introduction: Chimerism after orthotopic liver transplantation (OLT) has largely been
investigated in intrahepatic cellular constituents. However, little is known about
chimerism in the extrahepatic and large intrahepatic bile ducts. Our aim was to evaluate
the presence and extent of chimerism after OLT in the peribiliary glands (PBG) and the
luminal epithelium of the large donor bile ducts.
Methods: For this study, we examined six extrahepatic and large intrahepatic bile
ducts from livers that were re-transplanted. In all cases there was a sex-mismatch
between donor and recipient (female donor organ and male recipient), which allowed
to discriminate between donor- and recipient-derived cells. Specimens from female to
female transplants were used as negative controls and male to male transplants as
positive controls. Fluorescence in situ hybridization (FISH) for Y and X chromosomes
was performed and the percentage of XY positive cells was determined among
biliary epithelial cells. Immunohistochemistry was used to correlate chimerism with
histological features.
Results: Cholangiocellular chimerism in all studied specimens ranged from 14 to 52%.
The degree of chimerism was not associated with biliary damage. Marked chimerism
was present at 5 days post-OLT. Ki-67-positivity was detected in 1–8% of the epithelial
cells at the time of liver re-transplantation, and this correlated inversely with the
degree of chimerism.
Conclusion: Recipient-derived cholangiocytes are present in the large bile ducts of the
donor liver after OLT. The presence of chimerism in the large bile ducts suggests that
recipient-derived cells may play a role in biliary regeneration following ischemia-induced
injury during OLT.
Keywords: fluorescence in situ hybridization, peribiliary glands, liver transplantation, post-transplant
cholangiopathy, regeneration
Abbreviations: α-SMA, alpha-smooth muscle actin; CD45, cluster of differentiation 45; CK19, cytokeratin 19; DAPI,
4,6-diamidino-2-phenylindole; FISH, fluorescence in situ hybridization; H&E, hematoxylin and eosin; OLT, orthotopic
liver transplantation; PBG, peribiliary gland; PBS, phosphate-buffered saline; PSC, primary sclerosing cholangitis; SSC,
saline-sodium citrate buffer; vWF, von Willebrand factor.
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INTRODUCTION
Post-transplant cholangiopathies continue to be a major
challenge in clinical liver transplantation, in terms of morbidity
and mortality. Incidence rates range between 1 and 30%,
depending on variations in ischemia times and donor variables
(Abt et al., 2003; Dubbeld et al., 2010). After cold ischemic
preservation, up to 90% of the donor livers present with
histological evidence of luminal epithelium injury of the
extrahepatic and large intrahepatic bile ducts (op den Dries et al.,
2014). Yet, a relatively small proportion of these livers develops
a post-transplant cholangiopathy. Recent work suggests that
this discrepancy is based on the successful versus unsuccessful
regeneration of the luminal epithelium after orthotopic liver
transplantation (OLT) (Karimian et al., 2013; op den Dries et al.,
2014; de Jong et al., 2019).
Peribiliary glands (PBG) are progenitor/stem cell niches
arranged in a three-dimensional peribiliary network in the wall
of large bile ducts (Carpino et al., 2012; DiPaola et al., 2013).
Besides their exocrine function, PBG cells play a pivotal role in
the restoration of damaged biliary epithelium (de Jong et al.,
2018; Overi et al., 2018). In an ex vivo model mimicking
OLT, PBG cells started to proliferate 24 h after severe ischemic
injury and formed new patches of biliary epithelium 72 h
later (de Jong et al., 2019). This suggests that PBG contribute
to epithelial healing after cold ischemic preservation-induced
bile duct injury after OLT. However, in some cases also PBG
cells are injured during transplantation requiring remodeling
of these microscopic structures (op den Dries et al., 2014;
de Jong et al., 2019).
While chimerism, characterized by the presence of recipient-
derived cells among donor cells, has been shown to play a role
in tissue remodeling and repair of the liver parenchyma after
OLT (Theise et al., 2000b; Kleeberger et al., 2002; Hove et al.,
2003), it is unknown whether chimerism also plays a role in
regeneration of the biliary epithelium of the larger donor bile
ducts. We aimed to assess the role of recipient-derived cells in
the restoration of biliary epithelium of large donor bile ducts
after OLT. In this study, we describe chimerism in both the
luminal epithelium and PBG of the donor large bile ducts after
OLT. We propose a thus far undescribed origin of recipient-
derived cells and speculate that post-OLT remodeling of the PBG
network contributes to chimerism in the large ducts. This finding
may have important implications for our understanding of the
pathogenesis of post-transplant cholangiopathies.
MATERIALS AND METHODS
Preparation of Human Large Bile Duct
Specimens
Tissue from the large donor bile duct (proximal to the
anastomosis) of six adult male patients that previously received
a female full-sized liver graft were obtained during re-
transplantation. Appropriate negative controls (female recipients
that received a female donor liver, n = 3) and positive
controls (male recipients that received a male donor liver,
n = 3) were included. The reason for re-transplantation in
the study group included distinct pathological liver and bile
duct conditions (Table 1). The diagnosis for post-transplant
cholangiopathy was made clinically by endoscopic retrograde
cholangiopancreatography (ERCP), magnetic resonance imaging
(MRI) or percutaneous transhepatic cholangiography. Post-
transplant cholangiopathy was defined as strictures, dilatations,
or irregularities of the intra- or extrahepatic bile ducts of
the liver graft in absence of hepatic artery thrombosis. The
pathological conditions of the explanted liver and bile duct
were confirmed histologically after re-transplantation. In our
center, liver and bile duct explants are routinely biopsied and
stored for analysis. Archived formalin-fixed, paraffine embedded
(FFPE) tissue blocks from liver re-transplantations performed
between 2007 and 2013 were retrieved. Paraffin-embedded
tissue blocks were cut in specimens of 3 µm thickness and
attached to adhesive glass slides. All procedures and the




Sections were prepared for hematoxylin and eosin (H&E)
staining for histological injury assessment. All bile duct sections
were examined in a blinded fashion by two experienced
liver pathologists (MVDH and ASHG). Immunohistochemistry
for cytokeratin 19 (CK19), von Willebrand factor (vWF),
alpha-smooth muscle actin (α-SMA), Ki-67 and cluster of
differentiation 45 (CD45) was performed for histological
characterization of the sections. The immunostaining for CD45
was performed by using an automated immunostaining system
(Benchmark ULTRA; Roche Ventana Medical Systems, Tucson,
AZ, United States) and by applying the Ultraview DAB detection
kit of the same company. For all other immunostainings, tissue
sections were deparaffinized through a graded alcohol series and
rinsed in phosphate-buffered saline (PBS, pH 7.4). Endogenous
peroxidase activity was blocked by a 30-min incubation in H2O2.
Antigen retrieval for CK19 and α-SMA was performed with Tris–
HCl pH 9.0 buffer in a stove (80◦C) overnight, for vWF with
0.2% pepsine pH 2.0 and for Ki-67 with Tris–EDTA pH 9.0 buffer
in the microwave for 15 min. After PBS for 5 min, antibodies
for CK19 (CK19; Abcam, Cambridge, United Kingdom, dilution
of 1:100), vWF (vWF; DAKO, Glostrup, Denmark, dilution of
1:250), α-SMA (α-SMA, Sigma-Aldrich, Steinheim, Germany,
dilution 1:10.000), and Ki-67 (Ki-67; DAKO, Glostrup, Denmark,
dilution of 1:300) were applied for an hour. Next, a 30 min-
incubation was applied with peroxidase-labeled goat anti-rabbit
antibody (for CK19 and vWF) or rabbit anti-mouse antibody
(for α-SMA and Ki-67) in dilution 1:100. Rabbit anti-goat for
CK19 and vWF and goat-anti rabbit for α-SMA and Ki-67
were used as third antibodies (1:100 dilution). The staining
reaction was developed by 3,3’-diaminobenzidine (DAB) and
counterstained with hematoxylin. Stained slides were scanned
by a digital scanner and processed by ImageScope. The relative
number of destroyed PBG was estimated by two (blinded)
independent researchers and a semi-quantitative (SQ) score was
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Days between OLT and
re-OLT
Donor age Donor type
1 Haema-
chromatosis
PTC 53 0:45 7:18 2255 45 DBD
2 HCV cirrhosis Recurrence
HCV
48 0:55 9:34 2145 41 DBD
3 PSC PNF 66 1:30 5:27 5 74 DCD
4 Liver cirrhosis PTC 50 0:43 8:31 1885 53 DBD
5 Liver cirrhosis PTC 68 0:40 8:51 84 62 DCD
6 PSC Recurrence
PSC
50 0:37 8:55 4290 54 DBD
CMV, cytomegalovirus; DBD, donation after brain death; DCD, donation after circulatory death; HCV, hepatitis C virus; OLT, orthotopic liver transplantation; PNF, primary
non-function; PSC, primary sclerosing cholangitis; PTC, post-transplant cholangiopathy; Re-OLT, liver re-transplantation.
applied (0 ≤ 1%; 1 = 1–25%; 2 = 25–50%; 3 = 50–75%; 4 = 75–
100%). Likewise, a SQ score for the number of inflammatory cells
around PBG in the section was evaluated by two independent
researchers, but a different SQ score was appropriate for the
observations (the cross-section with the least inflammatory cells
around PBG scored 1 and the section with the most inflammatory
cells around PBG scored 5, the other sections were compared
with these two extremities). To quantify vWF, α-SMA, and Ki-
67 expression, we used QuPath v0.2.0 to develop an appropriate
classifier for each staining (Bankhead et al., 2017). For vWF and
α-SMA we determined the positive pixel count with respect to all
counted pixels and for Ki-67 the positive cell count was calculated
with respect to all counted cells (i.e., the proliferation index).
Thereafter, a score 1–3 was applied to the outcomes to show
relative expression of the markers.
Fluorescence in situ Hybridization for
X and Y Chromosomes
Tissue sections were deparaffinized in xylene for 2×15 min,
dehydrated through a graded alcohol series, and then rinsed with
distilled water for 4 min. We used a tissue digestion kit for all
pretreatment and washing steps (product number: KBI-60004,
Kreatech Biotechnology, Leica Microsystems, Amsterdam,
Netherlands). Sections were incubated at room temperature for
30 min with 0.2 HCl and rinsed with distilled water. Then, to
make DNA accessible for hybridization, tissue slides were treated
with 8% sodium thiocyanate at 84 degrees for 40 min, rinsed
with 2xSSC, and incubated at room temperature with a pepsin
solution for 30 min that was 3 times renewed. Next, slides were
rinsed with distilled water and 2xSSC followed by dehydration
and air drying. 7–10 µl of a mixture of X [DXZ1, conjugated
with Platinum-Bright495 (green)] and Y [DYZ3, conjugated
with Platinum-Bright550 (red)] probes (Leica Microsystems,
Amsterdam, Netherlands) was applied to the air-dried sections.
A cover slip was applied and sealed with Fixogum. Denaturation
and hybridization were performed in a humidified chamber
(Thermobrite, Leica Biosystems, Amsterdam, Netherlands) at 80
degrees for 5 min and at 37 degrees for 16 h, respectively. Next,
sections were covered in 2xSSC/0.1% Igepal at room temperature
for 2 min followed by incubation with 0.4xSSC/0.3% Igepal at
72 degrees for 2 min and incubation with fresh 2xSSC/0.1%
Igepal at room temperature for 2 min. Sections were dehydrated,
airdried and counterstained with 4,6-diamidino-2-phenylindole
(DAPI)/antifade 1 µg/ml.
Fluorescence in situ Hybridization
Analysis
Fluorescence microscopy was performed using an Olympus BX63
microscope (Olympus corporation, Leiderdorp, Netherlands)
equipped with a CCD video camera and Bioview duet-3 Software.
We first scanned the cross-section at low power to allow for
a wide field of view. To confirm that the counted cells were
classified as epithelial cells – and not inflammatory cells - we
performed immunohistochemistry for CK19 and CD45 prior to
fluorescence in situ hybridization (FISH) on the same section.
The sections stained with CK19 and CD45 were first scanned
with the Bioview duet-3 Software, put in xylene for 1 week,
and, then, the sections were treated with FISH and scanned
again with the same software. Localization of PBG and luminal
epithelium was confirmed by the matching procedure in which
the fluorescence section was matched with histology. A total
of 25 fields of interest were selected using both the histology
and the fluorescence scan. Next, 25 photomicrographs of each
section were taken with green and red filter sets of Vysis (Abbott
Molecular, Illinois, IL, United States). All photomicrographs
were checked for accuracy. Photomicrographs in which no PBG
and luminal epithelium were present or not well-recognizable
were excluded. In addition, photomicrographs which showed
areas without red and green signal were also excluded. In
the end, two to nine photomicrographs of each biopsy in the
study group were analyzed. Nuclei in which a red signal (Y
chromosome) and green signal (X chromosome) were present
were counted as recipient-derived cells. Nuclei that contained
two green signals (X chromosomes) were counted as native
donor cells. Nuclei that did not show clear signals were excluded
from the counting.
Statistical Analysis
Continuous variables were presented as mean ± standard
deviation. GraphPad Prism 8 (GraphPad Software, La Jolla, CA,
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United States) was used for presenting data in graphs. The
Spearman correlation test and the Mann-Whitney U test to
calculate significance for non-parametric data were performed
using SPSS software version 23 for Windows (SPSS, Inc., Chicago,
IL, United States).
RESULTS
The initial indication for OLT, reason for re-transplantation,
recipient age, ischemia times, time between primary OLT and re-
transplantation, and donor age and type of the sex-mismatched
transplantations are summarized in Table 1. Three patients were
re-transplanted for post-transplant cholangiopathy. Recurrence
of primary sclerosing cholangitis (PSC) was diagnosed in one
patient and the other two patients underwent a liver re-
transplantation because of primary non-function and recurrence
of hepatitis C. The mean cold ischemia time for all donor
livers was 8:06 ± 1:30 (hr:min) and the mean of warm
ischemia times was 0:52 ± 0:20 (hr:min). The mean graft
survival (time between primary OLT and re-transplantation) was
1777 ± 1594 days.
Histological Characteristics of Large
Donor Bile Ducts at the Time of
Re-transplantation
The diameter of the lumens of all examined donor bile
ducts ranged from 1.7 to 7.8 mm, corresponding to the
common bile duct or to the right or left hepatic bile duct;
collectively called large ducts. Histologically, the bile duct
biopsy of patient #1, re-transplanted for a post-transplant
cholangiopathy, was marked by a largely intact epithelium
and mild chronic inflammation in the bile duct wall with
infiltration of lymphocytes and plasma cells. PBG showed
hyperplasia of both deep and periluminal PBG, mild chronic
inflammation with interstitial fibrosis between the acini, and
dilated ducts. The biopsy taken from the large donor bile duct
in patient #2, re-transplanted for recurrence of hepatitis C,
was characterized by an absent luminal epithelium. The wall
showed moderate chronic inflammation with fibrotic features.
The periluminal PBG were relatively intact with desquamation
of the epithelium and deep PBG were absent (Figure 1A: top
panel, left). Patient #3 underwent re-transplantation 5 days
after the primary OLT because of primary non-function of
the graft. The bile duct biopsy was characterized by a largely
detached luminal epithelium but otherwise normal cytology. The
bile duct wall appeared fibrotic without apparent inflammation.
PBG were scarcely present; one possible remnant of periluminal
PBG showed one duct and one atrophic acinus. Two deeper
located PBG showed similar changes. In other areas, more
PBG were present that contained interstitial fibrosis and mild
inflammation. Patient #4 was re-transplanted because of a
post-transplant cholangiopathy. The biliary lumen was dilated,
contained a bile cast and necrotic debris (Figure 1A: top
panel, center). The luminal epithelium was largely absent
due to necrosis, however, the epithelial cells present were
detached and showed infiltration by inflammatory cells and
some nuclear atypia. The deep and periluminal PBG were
surrounded and infiltrated by lymphoplasmacytic inflammatory
cells. Especially the periluminal PBG were destroyed. Patient
#5 underwent re-transplantation because of a post-transplant
cholangiopathy. The large donor bile duct was necrotic with
necrotic/bilious debris in the lumen. The luminal epithelium
was largely absent and when present, partly detached without
atypia. Massive inflammation was observed in the wall with
lymphocytes, plasma cells, neutrophils, and macrophages. PBG
were destroyed by inflammation and some remnants of ducts
were seen with loss of surrounding acini. Patient #6 required
re-transplantation because of recurrence of PSC. The luminal
biliary epithelium was absent, and the bile duct wall was marked
by mild chronic inflammation. Destruction of the periluminal
PBG was observed with remnants of ducts. Deeper PBG showed
interstitial fibrosis, mild to moderate inflammation, and acinar
atrophy (Figure 1A: top panel, right). Hence, all biopsies
showed histological damage to the biliary epithelium and wall.
The biopsies corresponding to patients #4 and #5 that were
re-transplanted for a post-transplant cholangiopathy showed
the most extensive damage including necrosis of the biliary
wall and epithelium and the presence of bile casts. Damage
to PBG ranged from almost none (Figure 1A: top panel,
left) to severe (Figure 1A, top panel, right). Quantification of
damaged PBG showed that the highest number of destroyed
PBG were found in biopsies from patients #4, #5, and #6.
In the same patients, inflammation around PBG appeared
more extensive, compared to the other patients (Figures 1B,C).
PBG cells in bile ducts of all patients expressed CK19 which
confirms the biliary origin of these cells (Figure 1D). Next,
we evaluated the presence of micro-vessels around PBG (i.e.,
microvascular density), activation of myofibroblasts around PBG,
and the proliferation index in both the PBG and the luminal
epithelium using an appropriate classifier for each staining
(Figures 1E,F). The endothelial cell marker vWF showed the
highest microvascular density in biopsies of patients #2 and #6
(5.2 ± 3.3% positive pixels). In addition, myofibroblasts were
massively activated around PBG in patient #5 (31.0 ± 17.6%
positive pixels) and the highest percentage of proliferating cells
was found in the biopsy of patient #6 (2.7 ± 2.7% positive
cells) (Figure 1F).
Recipient-Derived Cells Are Present in
the Large Donor Bile Ducts
FISH analysis of X- and Y-chromosomes was used to detect
male recipient-derived cells in the female donor bile ducts.
Fluorescence and histology images were matched (Figure 2A)
in order to make an overlay with two exactly the same
images (Figure 2B). Using this method, cells that were
counted to calculate cholangiocellular chimerism were
CK19+. Cells that stained positive for CD45, a marker
for inflammatory cells (e.g., macrophages, neutrophils,
plasma cells, and lymphocytes) were excluded from the
chimerism counting. Cells that were counted as recipient-
derived epithelial cells (XY) or as donor-derived epithelial
cells (XX) were negative for CD45 (Figure 2C and
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FIGURE 1 | Histological characterization of large donor bile ducts from six patients that received a sex-mismatched liver graft. (A) Hematoxylin and eosin (H&E)
staining of the large donor bile ducts; the panels from left to right correspond to numbers 2, 4, and 6 in the tables. Patient #2 required a liver re-transplantation
because of recurrence of hepatitis C. Relatively intact peribiliary glands (PBG) are shown in the left panel (arrowhead), some with debris in their lumen and detached
epithelial cells. Patient #4 presented with a post-transplant cholangiopathy; disrupted luminal epithelium (arrow), infiltrative inflammatory cells, and a bile cast
(arrowhead) were observed (central panel). Patient #6 was re-transplanted because of recurrence of primary sclerosing cholangitis (PSC). Arrowheads point toward
damaged PBG (right panel). (B) Semiquantitative (SQ) score of destroyed PBG and inflammation around PBG. Patients #4, #5, and #6 presented with the highest
number of destroyed PBG and inflammation around PBG. (C) Immunohistochemistry for cluster of differentiation 45 (CD45). The red dotted line encircles clusters of
PBG. Inflammation was examined within this area. The inset is depicted from the larger image and shows PBG encircled by CD45+ inflammatory cells (arrowheads).
Scale bars: 250 µm. (D) Immunohistochemistry for cytokeratin 19 (CK19), confirming the biliary origin of the PBG cells. Arrowheads point toward CK19 positive
cells. (E) Immunohistochemistry for von Willebrand factor (vWF), alpha-smooth muscle actin (α-SMA), and Ki-67. For all three stainings, a specified classifier was
developed to determine the expression of vWF, α-SMA, and Ki-67 indicating the number of micro-vessels around PBG (i.e., microvascular density), myofibroblast
activation, and proliferating cells (i.e., proliferation index), respectively (F) Relative expression of vWF, α-SMA, and Ki-67. Microvascular density appeared the highest
in patient #2 and #6. Myofibroblast activation was most pronounced in patient #5. Patient #6 showed the highest proliferation index of the epithelial cell
compartment.
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FIGURE 2 | Cells that were included in the chimerism counting of the large donor bile ducts showed biliary commitment. (A) Matching procedure to match the
fluorescence in situ hybridization (FISH)-treated sections with immunohistochemistry. We used Bioview Duet-3 software to match an image of the FISH-treated
sections with immunohistochemistry allowing us to locate high-power FISH photomicrographs within the section and to determine cytokeratin 19 (CK19) expression
of individual FISH-treated cells. Two red-colored rectangles from the FISH overview are shown in the CK19 overview in the right image. (B) CK19 immunostainings
and FISH photomicrographs of PBG; the two CK19 immunostainings in the left images correspond with the two red-colored rectangles in the CK19 overview in
panel A. CK19 is a marker for biliary epithelial cells. Images that are horizontal aligned show the same area in the cross-section. Arrowheads in the left image point
toward CK19+ cells, these same cells are pointed out in the FISH photomicrograph and the merged image on the right side. These CK19+ epithelial cells were
included in the chimerism counting. (C) Immunohistochemistry for cluster of differentiation 45 (CD45) with matching FISH photomicrographs. CD45 is a marker for
inflammatory cells. Images that are horizontal aligned show the same area in the cross-section. Arrowheads point toward CD45+ cells in the CD45 immunostaining,
FISH photomicrograph, and the merged image. (D) Chimerism counting in CD45 and CK19 immunostainings merged with FISH photomicrographs. Black arrows
show that the left and right image in panel D are magnifications of the upper CD45-FISH merged image in panel C and the lower CK19-FISH merged image in panel
B, respectively. Male recipient-derived cells, encircled by a blue dotted line, present with red and green spots indicating Y and X chromosomes, respectively. Female
donor-derived cells, encircled by a pink dotted line, present with two green dots indicating two X chromosomes. In the image on the left side, a CD45 negative PBG
cell is depicted by an arrowhead (see also corresponding images in panel C) and magnified in the yellow box in the lower right corner. This recipient-derived cell can
therefore be classified as a non-inflammatory PBG cell (i.e., cholangiocyte). In the image on the right side, a CK19+ epithelial cell is pointed out by an arrowhead and
magnified in the yellow box in the lower right corner. Cells that are encircled by a blue or pink dotted line were included in the chimerism counting. (B–D) Original
magnification ×60.
Supplementary Figure 1). Figure 2D shows that counted
cells were CD45- and CK19+, confirming that recipient-derived
cells with biliary commitment were present in the large donor
bile ducts. The smaller panels represent recipient-derived
cells negative for CD45 (left panel) and positive for CK19
(right panel).
Detected by the presence of XY chromosomes, recipient-
derived cells were found in different ratios in all six large
duct biopsies of patients that received a sex-mismatched liver
graft (Table 2). Y-positive cells were consistently observed
in the male positive controls whereas none were found in
the negative controls (Supplementary Figure 2). Epithelial
chimerism ranged between 14 and 52% and was present
as soon as 5 days after OLT. There were no significant
differences in chimerism between patients re-transplanted for
biliary or non-biliary diseases. The donor livers that were
explanted because of a post-transplant cholangiopathy showed
relatively high percentages recipient-derived cholangiocytes (34,
43, and 25%), although the highest percentage cholangiocellular
chimerism (52%) was observed in the large bile duct of a
liver explanted for a non-biliary disease (Table 2). There
TABLE 2 | Chimerism in the large donor bile ducts.
PBG Epithelium Overall
Study Number Count % Count % Count %
1 61/176 35 10/31 32 71/207 34
2 14/27 52 − − 14/27 52
3 20/138 14 16/118 14 36/256 14
4 − − 9/12 43 9/12 43
5 13/46 28 16/69 23 29/115 25
6 37/277 13 4/21 16 41/298 14
Total 145/664 22 55/264 21 200/928 22
PBG, peribiliary glands.
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FIGURE 3 | Recipient-derived cells in PBG of the large donor bile ducts. (A) Hematoxylin and eosin (H&E) staining corresponding with number 1 in the tables.
High-power photomicrographs were obtained from different sites of the bile duct sample; two photomicrographs of this cross-section are displayed in panels (B,C).
The sites marked in the H&E staining correspond with the photomicrographs in panel (B,C). (B) FISH photomicrograph. Male recipient-derived cells, encircled by a
blue dotted line, present with red and green spots indicating Y and X chromosomes, respectively. Female donor-derived cells, encircled by a pink dotted line, present
with two green dots indicating two X chromosomes. Yellow arrowheads point toward red spots in the cells indicating Y chromosomes, the hallmark of
recipient-derived cells. Cells that are encircled by a blue or pink dotted line were included in the chimerism counting. (C) FISH photomicrograph. Pink and blue
dotted lines indicate epithelial cells that were included in the chimerism counting. Surrounding cells are marked with an unbroken line, these cells were not included
in the chimerism counting. Yellow arrowheads point toward the red dots of PBG cells indicating Y chromosomes. Red arrowheads point toward red dots of
surrounding cells indicating Y chromosomes. In both cell populations (i.e., epithelial cells and surrounding cells) multiple recipient-derived cells were observed.
(D) Schematic drawing of the bile duct anastomosis after orthotopic liver transplantation (OLT). Microscopic structures in the large bile ducts of the donor and
recipient are juxtaposed after an end-to-end anastomosis by surgical sutures. Both the recipient and the donor PBG network possess a facultative stem/progenitor
cell population that is activated after loss of biliary tissue. We propose a thus far undescribed mechanism in which post-OLT remodeling of the PBG network of the
recipient contributes to regeneration of the donor large bile duct (yellow arrowheads). By this means, PBG remodeling could contribute to chimerism in the luminal
epithelium and PBG of the large donor bile duct. (B,C) Original magnification ×60.
were no significant differences in the number of recipient-
derived cells counted in the luminal epithelium and PBG
cells. Interestingly, some areas displayed no recipient-derived
cells at all, whereas other regions of the same cross-section
showed up to 30% cholangiocellular chimerism suggesting that
recipient-derived cells were clonally distributed throughout
the donor bile duct. None of the histological or clinical
features (e.g., inflammation, destroyed PBG, microvascular
density, myofibroblast activation, recipient age, ischemia times
and days between transplantations) correlated with epithelial
chimerism, except for the proliferation index. The percentage of
positive Ki-67 cells correlated inversely with epithelial chimerism
(R2 = −0.81; P = 0.037). Figure 3 summarizes the present study
in which matched photomicrographs were taken (Panel A) and
analyzed for the presence of recipient-derived cells (Panel B,
C: pointed out by yellow arrowheads and encircled by a blue
dotted line). In addition, surrounding non-epithelial solitary cells
of which some with elongated nuclei (i.e., mesenchymal cells)
were found to be a mixed population of XY and XX genotypes
(Figure 3C: pointed out by red arrowheads and encircled by an
unbroken line). These surrounding cells were not included in the
chimerism counting.
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DISCUSSION
In the present study, we demonstrated the presence of CK19
positive and CD45 negative recipient-derived cells in the donor
large bile ducts. Epithelial chimerism ranged between 14 and
52% and was observed as soon as 5 days after OLT. Evidence of
cell proliferation was observed in 1–8% of the biliary epithelial
cells at time of liver re-transplantation, and this correlated
inversely with the extent of chimerism. Clustered localization of
recipient-derived cholangiocytes suggested a clonal expansion.
While chimerism after OLT has largely been investigated in
intrahepatic cellular constituents, this is the first study in
which cholangiocellular chimerism is demonstrated in the large
donor bile ducts.
We could not find a relationship between the extent of
chimerism and the time interval between OLT and sampling at
re-transplantation. This is in accordance with an earlier study
in which a time-dependent correlation was observed for hepatic
chimerism, but not for chimerism of the intrahepatic small
cholangiocytes. In that study, more hepatocellular chimerism
was observed in liver biopsies taken at a longer time interval
after OLT, compared to biopsies taken early after the procedure,
whereas such pattern was not noted for the small intrahepatic
cholangiocytes (Theise et al., 2000b). In contrast to this, the
presence of recipient-derived hepatocytes has been suggested to
be a relatively early event (Fogt et al., 2002; Idilman et al., 2004,
2007) or not time-dependent at all (Kleeberger et al., 2002).
The extent of biliary injury did not seem to influence the
engraftment of recipient-derived cells. Moreover, microvascular
density, myofibroblast activation, and inflammation were not
correlated with cholangiocellular chimerism. Most severe damage
was observed in the bile ducts of patients #4 and #5 and
the least severe biliary damage in patient #1. All these
three patients suffered from post-transplant cholangiopathies,
but cholangiocellular chimerism rates in these patients were
moderate, compared to the others. As reflected by the
radiographic presentation of post-transplant cholangiopathies,
biliary lesions are often discontinuous along the biliary tree.
The morphological abnormalities we observed in the present
study may therefore have been influenced by “sampling error.”
Moreover, damage or loss of epithelial cells may have influenced
the extent of chimerism: Loss of recipient-derived epithelial cells
in the donor bile duct later in the disease development due to
ongoing injuries can, unfortunately, not be quantified, thus the
accumulative number of recipient-derived cells remains elusive.
Chimerism of intrahepatic small cholangiocytes in a study
of Theise et al. (2000b) ranged between 4 and 38%, which is
somewhat lower than the chimerism of the large cholangiocytes
observed in the current study. Other studies reported even
a lower number of intraparenchymal recipient-derived cells
with biliary differentiation (Kleeberger et al., 2002; Hove et al.,
2003). The extent of hepatocellular chimerism ranged between
2 and 40% and only some studies suggested a correlation with
hepatic damage (Kleeberger et al., 2002; Hove et al., 2003;
Idilman et al., 2004).
Up to date, multiple studies have demonstrated recipient-
derived cells in organ allografts (Bittmann et al., 2001;
Quaini et al., 2002; Boersema et al., 2009). Two questions
remain unanswered as results have been equivocal and various
regenerative mechanisms presumably overlap: (1) What is the
origin of the recipient-derived cells? And (2) why are native
donor cells replaced by recipient cells?
Regarding the first question, various theories have been
proposed to explain hepatic chimerism: fetal microchimerism,
bone marrow-derived stem cells, cell fusion, and circulating
epithelial cells. The first one refers to fetal cells that are known
to persist in the maternal circulation after pregnancy which could
explain non-self cells in the donor liver after OLT (Fanning
et al., 2000; Baccarani et al., 2001). Two previous studies
have precluded fetal microchimerism as (single) source for the
observed recipient-derived hepatocytes and intrahepatic small
cholangiocytes (Hove et al., 2003; Idilman et al., 2007). Bone-
marrow derived stem cells are widely accepted as an origin
of intraparenchymal recipient-derived cells after OLT as this is
confirmed with mouse and human experiments (Petersen et al.,
1999; Theise et al., 2000a,b). Cell fusion between hematopoietic
stem cells and hepatocytes has been described, but appears to be
very rare and its contribution to post-OLT chimerism is therefore
considered trivial (Wang et al., 2003). Circulating epithelial cells
are another putative source of recipient-derived hepatic cells after
OLT, but this has, actually, never been investigated in this setting
(Roos et al., 2019).
Based on our results, we propose an as yet undescribed
mechanism for the presence of cholangiocellular chimerism in
the large donor bile ducts after OLT (see Figure 3D). PBG
contain a facultative progenitor compartment that is known
to have the capacity to migrate and replenish biliary luminal
epithelium after severe injury (DiPaola et al., 2013; Carpino
et al., 2019; de Jong et al., 2019). During an OLT, the donor
and recipient extrahepatic bile duct are connected through an
end-to-end anastomosis. After implantation of the liver allograft,
liver and bile duct regenerate the injured and lost tissue afflicted
by ischemia-reperfusion injury. In this setting, recipient PBG
cells might contribute to the regeneration of the donor luminal
epithelium. In an ex vivo human bile duct slice model, PBG
cells were shown to replicate, mature and migrate toward several
denuded surfaces within 3 days (de Jong et al., 2019). This finding
suggests that recipient PBG cells are able to migrate through
stroma contributing to PBG and luminal epithelium wound
healing of the large donor bile ducts (Carpino et al., 2019). In
addition, in a pig model of extrahepatic bile duct replacement
by a biodegradable tubular polymer scaffold, PBG appeared
to be the first cholangiocellular compartment to regenerate,
followed by regeneration of the luminal epithelium (Miyazawa
et al., 2005; Li et al., 2012). After 6 weeks of replacement of
the extrahepatic bile duct by the scaffold, PBG-like structures
were appearing in the scaffold, whereas the luminal biliary
epithelium reappeared at 10 weeks. After 6 months, stroma
tissue was thicker, luminal epithelium flatter, and the number
of PBG was equal to that of the controls (Miyazawa et al.,
2005). This suggests that PBG regeneration, or “remodeling”
is a primary feature of bile duct regeneration. Following these
observations, contribution of recipient PBG cells to the recovery
of the donor bile duct would be a relatively late event which is
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not in agreement with our results that show cholangiocellular
chimerism already after 5 days.
We therefore propose overlapping strategies in which
cholangiocellular chimerism contributes to accomplish tissue
repair: After implantation of the liver graft, bone-marrow derived
cells may be recruited to regenerate intraparenchymal cells after
ischemia-induced liver injury. These cells travel through the
blood stream and a proportion of hemopoietic stem cells may
be delivered to the liver whereas another proportion may engraft
in the damaged large ducts via the peribiliary vascular plexus.
Replication of engrafted hemopoietic stem cells in the donor
large ducts could explain the observed clonal distribution of
recipient-derived cells. Next to this process, PBG remodeling at
both the recipient and donor site of the large ducts may be the
primary event to regenerate luminal epithelium. In this process,
PBG cells from the recipient may be mobilized and contribute
to regeneration of the PBG and luminal epithelium of the donor
bile duct. This putative mechanism explains the higher number
of recipient-derived cells in the large bile ducts compared to small
intraparenchymal cholangiocytes (Theise et al., 2000b; Kleeberger
et al., 2002; Hove et al., 2003).
Regarding the second question, earlier studies (including the
present one) were not able to demonstrate a clear correlation
between liver and bile duct injury and the extent of post-OLT
hepatocellular or cholangiocellular chimerism (Kleeberger et al.,
2002; Hove et al., 2003; Idilman et al., 2004). Interestingly, in the
present study, chimerism and proliferation index were inversely
correlated. However, due to the relative small number of patients
included in this study, the results should still be confirmed in
larger series. By using sex-chromosomes for the identification
of recipient-derived cells in donor bile ducts, we were restricted
to male patients undergoing re-transplantation of a liver from
a female donor. This limited the number of patients we could
include in this study.
In addition, as applies equally for our study, detection of
recipient-derived cells relies on molecular experiments (Real-
Time Polymerase Chain Reaction and/or FISH) to label DNA
fragments in archival frozen or paraffine-embedded specimens.
These experiments are particularly challenging as proper
preservation of DNA fragments requires optimal conditions
during sample processing. Heterogeneity in sample processing
makes quantification of recipient-derived cells therefore rather
controversial and previously reported numbers may have been
under- or overestimated (Aini et al., 2013).
In conclusion, this study provides evidence for the presence
of recipient-derived cells in the large donor bile ducts after OLT.
Recipient-derived cells may contribute to regeneration of the
damaged donor bile duct and distinctive origins of these cells
could explain the divergent results obtained in liver chimerism
studies up to now. This study provides an opportunity for a wide
array of mechanistic studies, with the ultimate goal to identify
methods that can be applied to stimulate biliary regeneration.
These studies should focus on the source of recipient-derived cells
in the large donor bile ducts and address the question what the
drivers are behind biliary chimerism. To that end, lineage tracing
studies could confirm the source of recipient-derived cells and
expression profiles of high- and low-chimerism PBG could be
compared for deeper insights regarding chimerism-stimulators.
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